drugset / Trial / NCT02540239

Summary

To evaluate the efficacy, visibility of low volume polyethyleneglycol-simeticone (2-LPEG-S) for colonoscopy.

Timeline

Start
2015-01
Primary completion
2016-02
Completion
2016-04

Outcome

Met primary endpoint

paper More adenomas were detected in the PEG plus simethicone group than in the PEG alone group (ADR 21.0 % vs. 14.3 %, P = 0.04; PMID 28985630 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Simethicone Other / unclassified — —
Comparator polyethylene glycol Other / unclassified 2000 ml —

Indications